<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Of 27 patients with <z:hpo ids='HP_0001908'>hypoplastic anemia</z:hpo> treated between 1971 and 1974 with male hormone and protein-assimilating hormone, 3 developed superior sagittal sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> (SSST) </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical symptoms and signs and angiographic findings of SST were characteristic enough to allow an early diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>Signs related to SST were <z:hpo ids='HP_0001250'>seizures</z:hpo>, <z:hpo ids='HP_0002301'>hemiplegia</z:hpo>, <z:hpo ids='HP_0010628'>facial palsy</z:hpo>, stupor, and <z:hpo ids='HP_0001259'>coma</z:hpo>, with the most important prodrome and consistent subjective complaint being <z:hpo ids='HP_0002315'>headache</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Following discontinuation of the hormone therapy, neurological signs and symptoms related to SSST gradually subsided </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases, the hematological picture improved with discontinuation of the hormone therapies </plain></SENT>
<SENT sid="5" pm="."><plain>It appears that administration of male hormone can be associated with the development of SSST </plain></SENT>
<SENT sid="6" pm="."><plain>If neurological symptoms and signs of SSST appear, administration of the hormones should be discontinued </plain></SENT>
</text></document>